Trial Updates
There are new resources available on the EFIC tab of the KESETT website. Please review the following documents found on this page:
Memo: Discussion of KESETT at Community Events Prior to CIRB review
Please see the memo from KESETT Leadership regarding the discussion of KESETT at community events prior to CIRB review: To: KESETT Sites From: KESETT Leadership Re: Discussion of KESETT at …
KESETT – New Resource in the Workbench
We have added a new resource to the KESETT workbench. You can find the archive of the slides presented at the monthly SIREN study coordinator meeting in the workbench under …
Overview
Ketamine add-on therapy for Established Status Epilepticus Treatment Trial (KESETT)
A multicenter, randomized, blinded study of treatment of patients with benzodiazepine-refractory status epilepticus in the emergency department, with either levetiracetam or levetiracetam combined with 1 mg/kg or 3 mg/kg dose ketamine to determine which treatment leads to more effective control of status epilepticus.
Contact
Emergency 24-Hour Study Hotline:
To be announced
Education (training, website access, material development, technical support):
Courtney Miller ([email protected]) – Education Coordinator, or [email protected]
WebDCU Support (user account requests, technical support, CRF completion):
Sara Meyer ([email protected]) (843) 792-1599 & Riley Luckmann ([email protected]) (843) 792-1599
Site Management & General Inquiries:
Vincent Cervantes ([email protected]) or [email protected]
Finances:
Valerie Stevenson ([email protected])